Skip to main content
. Author manuscript; available in PMC: 2006 May 17.
Published in final edited form as: Arch Ophthalmol. 2001 Oct;119(10):1417–1436. doi: 10.1001/archopht.119.10.1417

Figure 6.

Figure 6

Repeated-measures estimates of the probability of a loss in the visual acuity score of at least 15 letters in at least 1 study eye of participants in age-related macular degeneration (AMD) Categories 3 and 4 by treatment group. The study eye is an eye without disqualifying lesions or evidence of advanced AMD and with a visual acuity score greater than 73 letters (20/32 or better) at baseline.